SynthesisRheumatology international2016

Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Sumit Kunwar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.